Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.79, $0.29 better than the analyst estimate of $5.50. Revenue for the quarter came in at $11.12 billion versus the consensus estimate of $10.91 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.